Parodontax

Parodontax is an oral-care brand best known for toothpaste and mouthwash positioned around gum health, plaque control, and the management of bleeding gums. The brand originated in Germany in 1937, when dentist Dr. Focke developed an early toothpaste based on sodium bicarbonate. It was subsequently acquired by Madaus, a German pharmaceutical company associated with herbal medicine. Madaus expanded the formula with plant-derived ingredients selected for their claimed anti-inflammatory and antibacterial properties, giving the toothpaste a distinctive composition and a salty herbal taste. The brand’s identity has historically been tied to periodontal care rather than general cosmetic oral care. Its traditional formula included sodium bicarbonate together with extracts or oils associated with medicinal plants, including krameria, echinacea, chamomile, myrrh, sage, and mint. Parodontax also developed products aimed at more direct treatment of gum conditions. In 1975, the brand introduced a toothpaste containing chlorhexidine digluconate in Germany. Chlorhexidine later became widely used in dental products for short-term management of gingivitis and related gum problems, including mouthwashes, sprays, and gels. GlaxoSmithKline acquired the brand in 2001 and continued production using the established formulation for a period. A significant reformulation followed in 2017, when the traditional herbal extracts were removed from the toothpaste. The revised product emphasized stannous fluoride as its active ingredient and sodium bicarbonate as an abrasive component. This change aligned the brand more closely with contemporary fluoride-based oral-care products while retaining its focus on gum bleeding and periodontal health. Parodontax products have been marketed in Germany, France, and other international markets. The brand is now owned by Haleon, the consumer-health company formed through the separation of GSK’s consumer-health business. Its portfolio is centered primarily on toothpaste, with mouthwash and other gum-care formats associated with the brand in different periods and markets. The clinical positioning of Parodontax has received both support and qualification. A 2015 systematic review reported short-term effects on plaque and gingival inflammation but noted that additional long-term research was needed to establish the durability of its anti-gingivitis benefits. Claims concerning the ability of the toothpaste to heal or reduce bleeding gums have therefore been discussed in relation to the strength and limits of available clinical evidence. Parodontax remains an active specialist oral-care brand whose differentiation comes from its gum-health positioning, sodium-bicarbonate heritage, fluoride formulations, and distinctive taste profile.

Parodontax was developed in Germany in 1937 by dentist Dr. Focke. The original toothpaste was based on sodium bicarbonate, a material that became central to the brand’s identity and later formulations. The product was acquired by Madaus, a German pharmaceutical company known for herbal medicine. Under Madaus, the formula was supplemented with plant-derived ingredients associated with traditional medicinal use, including extracts from krameria, echinacea, chamomile, and myrrh, together with sage and mint oils. These ingredients contributed to the product’s distinctive salty and herbal flavor and differentiated it from conventional mint toothpastes. The brand gradually expanded from a traditional toothpaste into a broader gum-care proposition. In 1975, Parodontax launched a toothpaste containing chlorhexidine digluconate in Germany. Chlorhexidine became an important ingredient in short-term products for gingivitis and other gum conditions, and related oral-care formats such as mouthwashes, sprays, and gels were developed over time. The brand’s historical emphasis was therefore not primarily cosmetic whitening or breath freshening, but the care of gums affected by plaque, inflammation, or bleeding. GlaxoSmithKline acquired Parodontax in 2001. GSK maintained the brand’s production and its association with the established formula for a number of years. In 2017, the toothpaste underwent a notable reformulation: the traditional herbal extracts were removed, while stannous fluoride became the principal active ingredient and sodium bicarbonate continued to serve as an abrasive. The change modernized the formula and placed greater emphasis on ingredients commonly used in contemporary fluoride oral-care products, although the brand continued to communicate around bleeding gums and gum health. Parodontax has been sold in Germany, France, and other markets internationally. Its assortment has included toothpaste as its central product, alongside mouthwash and other formats intended to support gum-care routines. The brand’s market identity has remained closely linked to its unusual flavor profile, its sodium-bicarbonate heritage, and its specialist periodontal positioning. Evidence concerning the brand’s benefits has been described with some caution. A systematic review published in 2015 found short-term effects on plaque and gingival inflammation but stated that longer-term research was needed to assess its effectiveness as an anti-gingivitis toothpaste. Claims that the product can heal bleeding gums have consequently been debated in the context of dental evidence and professional interpretation. This debate does not establish a corporate scandal, but it illustrates the importance of distinguishing symptom-focused marketing claims from the level of evidence available for long-term periodontal outcomes. Parodontax is currently owned by Haleon. The brand remains an active consumer-health product line focused on toothpaste and mouthwash for gum health, retaining a specialist identity within the broader oral-care category.

1. 2022Brand joins Haleon

   Parodontax becomes part of Haleon following the separation of GSK’s consumer-health business.

   Source
2. 2017Major toothpaste reformulation

   Traditional herbal extracts are removed, with stannous fluoride and sodium bicarbonate becoming the key highlighted formulation components.

   Source
3. 2015Systematic review assesses anti-gingivitis evidence

   A systematic review reports short-term effects on plaque and gingival inflammation but calls for longer-term studies.

   Source
4. 2001Acquisition by GlaxoSmithKline

   GlaxoSmithKline acquires the Parodontax brand and continues its production.

   Source
5. 1975Chlorhexidine formulation launches in Germany

   Parodontax introduces a toothpaste containing chlorhexidine digluconate, broadening its gum-disease treatment orientation.

   Source
6. 1937Original Parodontax toothpaste is developed

   Dentist Dr. Focke develops the original German toothpaste using sodium bicarbonate as its base.

   Source

A specialist oral-care brand focused on gum health, bleeding gums, plaque control, and periodontal-care routines, with a heritage in sodium-bicarbonate and herbal formulations.

• Parodontax toothpasteToothpaste1937

  The brand’s core product line is toothpaste positioned for gum health, plaque control, and bleeding-gum concerns. Its historical formula was based on sodium bicarbonate and included a range of herbal extracts and oils, producing a distinctive salty herbal taste. After the 2017 reformulation, the traditional herbal extracts were removed and the formula emphasized stannous fluoride as the active ingredient alongside sodium bicarbonate. Product composition and claims can vary by market and product generation.

• Parodontax chlorhexidine toothpasteMedicated toothpaste1975

  Introduced in Germany in 1975, this historical formulation contained chlorhexidine digluconate. It reflected Parodontax’s expansion into products associated with short-term management of gingivitis and gum disease. Chlorhexidine-based oral-care products have also included mouthwashes, sprays, and gels, although availability and formulation status may differ across markets.

• Parodontax mouthwashMouthwash

  Parodontax mouthwash is part of the brand’s broader gum-care portfolio. The format supports oral rinsing routines aimed at plaque, gingival inflammation, and gum health. Specific active ingredients, indications, and availability have varied by product and market.

• 2022Transfer of ownership from GSK consumer health to HaleonM&A

  GSK separated its consumer-health operations from the pharmaceutical business.

  What changed. Parodontax became part of Haleon, the standalone consumer-health company.

  Aftermath. The brand continued as an active Haleon oral-care line.

  Source
• 2017Reformulation removes traditional herbal extractsGeneration change

  The brand had long been associated with a sodium-bicarbonate base and a mixture of herbal extracts that contributed to its taste and heritage.

  What changed. The toothpaste formula was changed by removing the traditional herbal extracts and highlighting stannous fluoride as the active ingredient, with sodium bicarbonate retained as an abrasive.

  Aftermath. The change preserved Parodontax’s gum-health positioning while moving the product away from its historic herbal formulation.

  Source

• 2022Parodontax becomes part of Haleon

  Parodontax transfers to Haleon when GSK separates its consumer-health business into the new company.

  M&A
  Source
• 2017Parodontax removes traditional herbal extracts from toothpaste formula

  The toothpaste is reformulated without the historic herbal extracts, with stannous fluoride retained as the active ingredient and sodium bicarbonate used as an abrasive.

  Product generation
  Source
• 2001GSK acquires Parodontax

  GlaxoSmithKline obtains the Parodontax brand and continues its production.

  M&A
  Source
• 1975Parodontax introduces a chlorhexidine-containing toothpaste

  The brand launches a German product containing chlorhexidine digluconate, extending its focus into products associated with gum-disease treatment.

  Product launch
  Source
• 1937Parodontax toothpaste is developed in Germany

  Dentist Dr. Focke develops the original Parodontax toothpaste using sodium bicarbonate as its principal base.

  Product launch
  Source

1. Parodontax